Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-hour versus 21-hour acetylcysteine infusion for acute acetaminophen poisoning
IRCT20111003007710N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of acetylcysteine in acetaminophen poisoning (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Length of hospitalization. Started Apr 2022; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acetaminophen poisoning
Beyond the preview
Go deeper on IRCT20111003007710N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111003007710N2.